The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Some foods and drinks can worsen prostate health. Saturated fats ...